ProPhase Labs, Inc. Increase (Decrease) in Accounts Payable
ProPhase Labs, Inc. (PRPH) reported Increase (Decrease) in Accounts Payable of -$438.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-11-13
- ProPhase Labs, Inc. increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $681.00K.
- ProPhase Labs, Inc. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was $1.54M.
- ProPhase Labs, Inc. increase (decrease) in accounts payable for the quarter ending 2023-03-31 was -$2.66M, a 325.89% decline year-over-year.
- ProPhase Labs, Inc. increase (decrease) in accounts payable for the quarter ending 2022-09-30 was -$2.90M.
- ProPhase Labs, Inc. increase (decrease) in accounts payable for fiscal 2017 was -$1.59M, a 236.71% decline from fiscal 2016.
- ProPhase Labs, Inc. increase (decrease) in accounts payable for fiscal 2016 was $1.17M, a 260.99% increase from fiscal 2015.
- ProPhase Labs, Inc. increase (decrease) in accounts payable for fiscal 2015 was $323.00K.
- ProPhase Labs, Inc. increase (decrease) in accounts payable for fiscal 2014 was -$344.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2023-09-30 | $681.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.22M derived: sum of 2 quarters · filed 2023-11-13 | -$438.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$1.12M 10-Q · filed 2023-08-11 | ||
| 2023-03-31 | -$2.66M 10-Q · filed 2023-05-12 | |||
| 2022-09-30 | -$2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$6.66M derived: sum of 2 quarters · filed 2023-11-13 | -$5.48M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$3.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$2.58M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $1.18M 10-Q · filed 2023-05-12 | |||
| 2021-09-30 | -$5.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.75M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $3.34M 10-Q · filed 2022-08-12 | |||
| 2018-06-30 | -$99.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$117.00K 10-Q · filed 2018-08-20 | -$58.00K derived: sum of 3 quarters · filed 2018-08-20 | -$471.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2018-03-31 | -$18.00K 10-Q/A · filed 2018-08-20 | $41.00K derived: sum of 2 quarters · filed 2018-08-20 | -$372.00K derived: sum of 3 quarters · filed 2018-08-20 | -$15.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2017-12-31 | $59.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | -$354.00K derived: sum of 2 quarters · filed 2018-08-20 | $3.00K derived: sum of 3 quarters · filed 2018-08-20 | -$1.59M 10-K/A · filed 2018-08-20 |
| 2017-09-30 | -$413.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-08-20 | -$56.00K derived: sum of 2 quarters · filed 2018-08-20 | -$1.65M 10-Q/A · filed 2018-08-20 | -$1.47M derived: sum of 4 quarters · filed 2018-08-20 |
| 2017-06-30 | $357.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | -$1.24M 10-Q/A · filed 2018-08-20 | -$1.05M derived: sum of 3 quarters · filed 2018-08-20 | -$456.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2017-03-31 | -$1.60M 10-Q/A · filed 2018-08-20 | -$1.41M derived: sum of 2 quarters · filed 2018-08-20 | -$813.00K derived: sum of 3 quarters · filed 2018-08-20 | -$1.00M derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-12-31 | $188.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $784.00K derived: sum of 2 quarters · filed 2018-08-20 | $594.00K derived: sum of 3 quarters · filed 2018-08-20 | $1.17M 10-K/A · filed 2018-08-20 |
| 2016-09-30 | $596.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-08-20 | $406.00K derived: sum of 2 quarters · filed 2018-08-20 | $978.00K 10-Q/A · filed 2018-08-20 | $1.05M derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-06-30 | -$190.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-08-20 | $382.00K 10-Q/A · filed 2018-08-20 | $453.00K derived: sum of 3 quarters · filed 2018-08-20 | $726.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2016-03-31 | $572.00K 10-Q/A · filed 2018-08-20 | $643.00K derived: sum of 2 quarters · filed 2018-08-20 | $916.00K derived: sum of 3 quarters · filed 2018-08-20 | $331.00K derived: sum of 4 quarters · filed 2018-08-20 |
| 2015-12-31 | $71.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-08-20 | $344.00K derived: sum of 2 quarters · filed 2018-08-20 | -$241.00K derived: sum of 3 quarters · filed 2018-08-20 | $323.00K 10-K/A · filed 2018-08-20 |
| 2015-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$312.00K derived: sum of 2 quarters · filed 2016-11-14 | $252.00K 10-Q · filed 2016-11-14 | -$1.19M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | -$585.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$21.00K 10-Q · filed 2016-08-11 | -$1.46M derived: sum of 3 quarters · filed 2017-02-24 | -$753.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $564.00K 10-Q · filed 2016-05-13 | -$877.00K derived: sum of 2 quarters · filed 2017-02-24 | -$168.00K derived: sum of 3 quarters · filed 2017-02-24 | $239.00K derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$732.00K derived: sum of 2 quarters · filed 2017-02-24 | -$325.00K derived: sum of 3 quarters · filed 2017-02-24 | -$344.00K 10-K · filed 2017-02-24 |
| 2014-09-30 | $709.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $1.12M derived: sum of 2 quarters · filed 2015-11-13 | $1.10M 10-Q · filed 2015-11-13 | $810.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-06-30 | $407.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $388.00K 10-Q · filed 2015-08-12 | $101.00K derived: sum of 3 quarters · filed 2016-03-29 | $372.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2014-03-31 | -$19.00K 10-Q · filed 2015-05-13 | -$306.00K derived: sum of 2 quarters · filed 2016-03-29 | -$35.00K derived: sum of 3 quarters · filed 2016-03-29 | $314.00K derived: sum of 4 quarters · filed 2016-03-29 |
| 2013-12-31 | -$287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$16.00K derived: sum of 2 quarters · filed 2016-03-29 | $333.00K derived: sum of 3 quarters · filed 2016-03-29 | -$285.00K 10-K · filed 2016-03-29 |
| 2013-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $620.00K derived: sum of 2 quarters · filed 2014-11-13 | $2.00K 10-Q · filed 2014-11-13 | $761.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-06-30 | $349.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$269.00K 10-Q · filed 2014-08-12 | $490.00K derived: sum of 3 quarters · filed 2015-03-27 | $501.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-03-31 | -$618.00K 10-Q · filed 2014-05-12 | $141.00K derived: sum of 2 quarters · filed 2015-03-27 | $152.00K derived: sum of 3 quarters · filed 2015-03-27 | -$144.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2012-12-31 | $759.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $770.00K derived: sum of 2 quarters · filed 2015-03-27 | $474.00K derived: sum of 3 quarters · filed 2015-03-27 | $411.00K 10-K · filed 2015-03-27 |
| 2012-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$285.00K derived: sum of 2 quarters · filed 2013-11-13 | -$348.00K 10-Q · filed 2013-11-13 | -$189.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-06-30 | -$296.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$359.00K 10-Q · filed 2013-08-13 | -$200.00K derived: sum of 3 quarters · filed 2014-03-27 | $395.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-03-31 | -$63.00K 10-Q · filed 2013-05-10 | $96.00K derived: sum of 2 quarters · filed 2014-03-27 | $691.00K derived: sum of 3 quarters · filed 2014-03-27 | $508.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2011-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $754.00K derived: sum of 2 quarters · filed 2014-03-27 | $571.00K derived: sum of 3 quarters · filed 2014-03-27 | $396.00K 10-K · filed 2014-03-27 |
| 2011-09-30 | $595.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $412.00K derived: sum of 2 quarters · filed 2012-11-14 | $237.00K 10-Q · filed 2012-11-14 | -$35.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | -$183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$358.00K 10-Q · filed 2012-08-13 | -$630.00K derived: sum of 3 quarters · filed 2013-03-28 | -$101.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | -$175.00K 10-Q · filed 2012-05-11 | -$447.00K derived: sum of 2 quarters · filed 2013-03-28 | $82.00K derived: sum of 3 quarters · filed 2013-03-28 | |
| 2010-12-31 | -$272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $257.00K derived: sum of 2 quarters · filed 2013-03-28 | -$219.00K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $529.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $53.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$476.00K 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | -$109.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |